While the drug aims to help clear the virus faster and reduce acute symptoms, there isn't a clear connection between that reduction and fewer instances of Long-COVID, one study has found.
While psychedelics are still illegal under U.S. federal law, companies are jostling to try and patent key ingredients found in magic mushrooms, ayahuasca and other substances.